-transparent.png){kind=logo}
A diffusible factor produced and secreted by malignant murine cells was capable of inducing plasminogen activator production by normal diploid human fibroblasts. The factor's ability to induce plasminogen activator was insensitive to treatment with nucleases, but its activity was destroyed by digestion with proteases. It is proposed that such a factor would play a role in malignancy if it would recruit normal cells that were adjacent to transformed cells to produce plasminogen activator which could result in tumor-promoted proteolysis.
Related Publications
R L Davies, and
D B Rifkin, and
R Tepper, and
A Miller, and
R Kucherlapati
April 1978,
Cancer research,
R L Davies, and
D B Rifkin, and
R Tepper, and
A Miller, and
R Kucherlapati
August 1986,
The British journal of dermatology,
R L Davies, and
D B Rifkin, and
R Tepper, and
A Miller, and
R Kucherlapati
January 1986,
Endocrinology,
R L Davies, and
D B Rifkin, and
R Tepper, and
A Miller, and
R Kucherlapati
May 1981,
Molecular and cellular biology,
R L Davies, and
D B Rifkin, and
R Tepper, and
A Miller, and
R Kucherlapati
April 1984,
The British journal of dermatology,
R L Davies, and
D B Rifkin, and
R Tepper, and
A Miller, and
R Kucherlapati
May 1977,
Biochemistry,
R L Davies, and
D B Rifkin, and
R Tepper, and
A Miller, and
R Kucherlapati
January 1994,
The Journal of clinical endocrinology and metabolism,
R L Davies, and
D B Rifkin, and
R Tepper, and
A Miller, and
R Kucherlapati
May 1989,
Experimental cell research,
R L Davies, and
D B Rifkin, and
R Tepper, and
A Miller, and
R Kucherlapati
July 1981,
The Journal of biological chemistry,
R L Davies, and
D B Rifkin, and
R Tepper, and
A Miller, and
R Kucherlapati
April 1982,
Biochimica et biophysica acta,
